Dorian Gray Syndrome of Upfront Immunotherapy in Patients With Non–Small-Cell Lung Cancer and High PD-L1 Expression

Lizza E.L. Hendriks, Jordi Remon, Benjamin Besse

    Research output: Contribution to journalComment/debate

    Original languageEnglish
    Pages (from-to)e87-e89
    JournalClinical Lung Cancer
    Volume23
    Issue number2
    DOIs
    Publication statusPublished - 1 Mar 2022

    Keywords

    • Immune checkpoint inhibition
    • Programmed death-ligand 1
    • non-small cell lung cancer
    • phase III clinical trials
    • real-world data

    Cite this